Cronyism’s Costs Are Bad for Our Health, Competition is the Cure
In the wake of the Affordable Care Act, we’ve seen a sharp increase in consolidation amongst hospitals and insurance companies. However, there is no strong evidence that this trend is having a positive impact on health outcomes.
At our upcoming Boston Professional salon dinner, Paul Howard of the Manhattan Institute and Yevgeniy Feyman from the Harvard School of Public Health will argue that when hospital systems and insurers try to be the biggest player in the game, it’s the patients who are left on the sidelines.
Join Howard and Feyman to discuss how hospital consolidation is like sumo wrestling; why cronyism has taken hold of our healthcare systems; and what needs to be done to encourage transparency, innovation in healthcare technology, and affordability for patients.
About the Speakers
Paul Howard is a senior fellow at the Manhattan Institute and director of health policy. He is a contributor to The Apothecary, the Forbes blog on health-care policy and entitlement reform, and a regular columnist for The Morning Consult. Along with Peter Huber, he is the co-author of Unlocking Precision Medicine (Encounter Books, 2016).
Howard has written on a wide variety of medical-policy issues, including FDA reform, biopharmaceutical innovation, consumer-driven health care, and Medicare and Medicaid reform. He is often quoted on health-care issues, and his work has appeared in such publications as Bloomberg View, New York Times, Wall Street Journal, National Affairs, USA Today, RealClearPolitics, New York Post, Investor’s Business Daily, Health Affairs, and FoxNews.com. He is a member of MI’s Project FDA.
Howard was part of the health-care policy advisory group for Mitt Romney’s 2012 presidential campaign, has testified three times before Congress, and, during 2013–16, served on an expert panel as a judge for Celgene’s Innovation Impact Awards. He joined MI in 2000, as deputy director of its Center for Legal Policy, where he edited research papers, managed legal-policy analyses, and organized conferences. He holds a B.A. from the College of the Holy Cross and a Ph.D. in political science from Fordham University.
Yevgeniy Feyman is an adjunct fellow at the Manhattan Institute. He writes on health care policy, entitlement reform, and the Affordable Care Act. His research has focused on a variety of topics, including the physician shortage, the cost of health care reform, and consumer-directed health care. Feyman was previously the deputy director of health policy at the Manhattan Institute and is currently a research assistant in the department of health policy at the Harvard T.H. Chan School of Public Health.
Feyman has written for publications including National Affairs, The New York Times's Room for Debate, Boston Globe's STAT, Health Affairs, and Politico. He has spoken on numerous radio and TV shows and is a contributor to The Apothecary, the Forbes health-care blog on health care policy and entitlement reform. Feyman holds a B.A. in economics and political science from Hunter College of the City University of New York.